SCHEMBL30764701

SCHEMBL30764701

Cc1cc(CN2CC3(C2)CN(C(=O)Cc2ccc(F)cc2)C3)no1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
TP53 P04637 1/20 0.41
GRIN2B Q13224 3/20 0.40
GRIN1 Q05586 2/20 0.40
POLB P06746 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP19A1 P11511 1/20 0.38
LMNA P02545 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ME2 P23368 1/20 0.37
ME1 P48163 1/20 0.37
ME3 Q16798 1/20 0.37
RORC P51449 1/20 0.37
MLNR O43193 1/20 0.37
CYP3A4 P08684 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GRM5 P41594 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764763 0.89 HSD11B1 (0.46) HSD11B1SMN1; SMN2LMNARECQL
SCHEMBL30764750 0.80 HSD11B1 (0.46) HSD11B1POLBALDH1A1SMN1; SMN2LMNA
SCHEMBL30764722 0.80 HSD11B1 (0.46) HSD11B1POLBALDH1A1SMN1; SMN2LMNA
SCHEMBL30764737 0.76 HSD11B1 (0.46) HSD11B1POLBALDH1A1SMN1; SMN2LMNA
SCHEMBL30764733 0.76 HSD11B1 (0.46) HSD11B1POLBALDH1A1SMN1; SMN2ME2
SCHEMBL30764731 0.74 HSD11B1 (0.56) HSD11B1POLBALDH1A1SMN1; SMN2ME2
SCHEMBL30764704 0.73 KMT2A (0.54) HSD11B1POLBALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL30764736 0.70 HSD11B1 (0.49) HSD11B1POLB
SCHEMBL30764734 0.69 KMT2A (0.54) HSD11B1POLB
SCHEMBL30764709 0.69 HSD11B1 (0.53) HSD11B1POLBALDH1A1SMN1; SMN2ME2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed